跳至主要内容
临床试验/NCT05075668
NCT05075668已完成不适用

Continuous Positive Airway Pressure Therapy Via Conventional CPAP Face Mask Versus High Flow Nasal Cannula in OSA Patients on the First Postoperative Night- a Pilot Randomised Study

Changi General Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Number of participants with documented desaturations (defined as >4% drop from baseline)

研究概览

简要总结

High flow, humidified, temperature-regulated nasal insufflation is not a new concept. It is used widely in the treatment of hypoxaemic respiratory failure in critically ill patients, as an alternative to non-invasive positive ventilation via face or nasal mask. Recently, its use has been extended to the perioperative setting for pre-oxygenation and prolonging apnoeic time to desaturation. Both CPAP and high flow nasal cannula insufflation devices are licensed for use clinically in Singapore. We conduct this pilot study because its perioperative use in our adult OSA population is currently not well-defined.

详细描述

Continuous positive airway pressure (CPAP) therapy is the only treatment for obstructive sleep apnoea (OSA) shown to reduce its long-term adverse effects on the cardiovascular system. However, due to difficult patient-mask interface and discomfort, compliance rate amongst patients with OSA is low, and reported to be only between 20-50%. High flow, humidified, temperature-regulated nasal cannula insufflation (of air or oxygen) is a well-documented and safe treatment in intensive care, paediatrics and respiratory medicine for patients with hypoxaemic respiratory failure. Its use in adult patients with obstructive sleep apnoea, especially in the perioperative setting is not well studied. Our hospital has a ''fast-track'' protocol for OSA patients who require surgery. They are started on CPAP therapy 2 to 5 days prior to surgery and in the immediate post operative period (ie. perioperatively). If these patients are non-compliant to the CPAP mask device, high flow nasal insufflation is a possible alternative treatment. We aim to randomise these patients into 4 groups, receiving conventional CPAP face mask or high flow nasal cannula at 3 flow rates, and study them with respect to incidence and number of documented desaturations. In addition, patient satisfaction, compliance to device and any adverse events will be monitored.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 21-85 years old presenting for elective surgery.
  • Suspected/possible OSA patients who are enrolled in the "fast-track OSA protocol" in the pre-assessment clinic
  • Patients started on CPAP therapy at least one day pre-operatively
  • Patients who are admitted to the High Dependency unit for postoperative monitoring.

排除标准

  • Patients with nasal obstruction.
  • Patients undergoing nasal or facial surgery, or surgery to treat OSA (eg. uvulopalatopharyngoplasty).
  • Patients who already require a higher oxygen concentration (FiO2 > 0.21) preoperatively.

结局指标

主要结局

Number of participants with documented desaturations (defined as >4% drop from baseline)

时间窗: 10 hours (between 10pm on first postoperative night and 8am the following day)

Number of documented desaturations (defined as \>4% below baseline) in OSA patients who receive CPAP face mask or high flow nasal insufflation on the first postoperative night

次要结局

  • Number of participants with any adverse effects of the applied therapy in the immediate postoperative setting.(10 hours (between 10pm on first postoperative night and 8am the following day))
  • Number of participants who need for supplemental oxygen and/ or the need for other interventions to reverse the desaturations.(10 hours (between 10pm on first postoperative night and 8am the following day))
  • Patients' perceptions of the comfort of each device on scale of 0 to 100(10 hours (between 10pm on first postoperative night and 8am the following day))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tsai Fung Chen

Consultant, Department of Anaesthesia & Surgical Intensive Care

Changi General Hospital

研究点 (2)

Loading locations...

相似试验

Efficacy of HFNC as an Alternative to CPAP Therapy... | 临床试验